New cancer clinical trial: Avelumab With Axitinib in Persistent or Recurrent Cervical Cancer After Platinum-based Chemotherapy

Published on: February 01, 2019 at 12:00PM
Condition:   Cervical Cancer
Interventions:   Drug: Avelumab;   Drug: Axitinib
Sponsor:   The University of Hong Kong
Not yet recruiting
http://bit.ly/2TszJuO